Canandaigua National Corp Eli Lilly & CO Transaction History

Canandaigua National Corp

$589 Million
Q4 2022

A detailed history of Canandaigua National Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Canandaigua National Corp holds 6,492 shares of LLY stock, worth $5.88 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

6,492

Previous 6,748 3.79%

Holding current value

$5.88 Million

Previous $2.18 Million 8.85%

% of portfolio

0.4%

Previous 0.39%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $82,316 - $95,915	-256 Reduced 3.79%	6,492 $2.38 Million
Q3 2022 Oct 05, 2022	SELL	$296.48 - $337.87 $166,918 - $190,220	-563 Reduced 7.7%	6,748 $2.18 Million
Q2 2022 Jul 05, 2022	SELL	$278.73 - $327.27 $91,702 - $107,671	-329 Reduced 4.31%	7,311 $2.37 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $117,814 - $146,413	-502 Reduced 6.17%	7,640 $2.19 Million
Q4 2021 Jan 04, 2022	BUY	$224.85 - $279.04 $47,218 - $58,598	210 Added 2.65%	8,142 $2.25 Million

Q3 2021 Oct 04, 2021	BUY	$221.6 - $272.71 $29,029 - $35,725	131 Added 1.68%	7,932 $1.83 Million
Q2 2021 Jul 06, 2021	SELL	$180.55 - $233.54 $8,666 - $11,209	-48 Reduced 0.61%	7,801 $1.79 Million
Q1 2021 Apr 05, 2021	SELL	$164.32 - $212.72 $368,405 - $476,918	-2,242 Reduced 22.22%	7,849 $1.47 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $33,397 - $44,193	-256 Reduced 2.47%	10,091 $1.7 Million
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $122,386 - $141,561	-837 Reduced 7.48%	10,347 $1.53 Million
Q2 2020 Jul 07, 2020	BUY	$136.42 - $164.18 $1.53 Million - $1.84 Million	11,184 New	11,184 $1.84 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.

Account

Canandaigua National Corp Eli Lilly & CO Transaction History